COMPETITIVE DRUG DEVELOPMENT INTERNATIONAL LIMITED

Active
Company number 06937090Private limited companyIncorporated 2009

Key figures

£84,434-29.4%
Net assets 2025
-16.2%
Average annual change 2020–2025
0100 k200 k300 k202020212022202320242025

Like most small UK companies, COMPETITIVE DRUG DEVELOPMENT INTERNATIONAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025

Sector comparison

SIC 82990

Where the company stands among the 160,475 active companies whose first SIC code is 82990 (Other business support service activities n.e.c.).

Net assets£84,434
Higher than 71% · median £13,199
Total assets£122,053
Higher than 61% · median £59,905
Cash£108,676
Higher than 71% · median £26,648
Employees1
Around the median · median 1
Company age17.4 years
Older than 75% · median 10.2 years

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 160,475. The line on each bar marks the median.

Summary: COMPETITIVE DRUG DEVELOPMENT INTERNATIONAL LIMITED

What kind of company is it?

COMPETITIVE DRUG DEVELOPMENT INTERNATIONAL LIMITED is a private limited company registered with Companies House under company number 06937090. It was incorporated on 17 Jun 2009. Its status is active. The registered office is in Godalming (GU7). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

How is the company doing financially?

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £84,434, down 29.4% on the previous year. Cash at bank and in hand was £108,676. The company had an average of 1 employee. Figures are available for 6 financial years (2020–2025).

How does it compare with similar companies?

Compared with 160,475 active companies whose first SIC code is 82990: By net assets it ranks higher than 71% of them (median £13,199). By total assets it ranks higher than 61% of them (median £59,905). By cash it ranks higher than 71% of them (median £26,648). By number of employees it is around the median of them (1). It is older than 75% of them (median age 10.2 years).

Who runs and controls the company?

The company has 2 current directors. One person with significant control is registered.

When are its next filings due?

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 1 Jul 2027.

Filed accounts2020–2025
20212022202320242025
Cash at bank and in hand180,025351,136138,375117,974108,676
Total assets307,569446,248186,293167,767122,053
Total liabilities—————
Net assets / total equity171,653250,129149,148119,54584,434
Average number of employees12211

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

History

23 events
  1. Financial year 2025 endedAccounts: net assets £84.4k, 1 employee
  2. Susan GOODMAN appointedDirector
  3. Financial year 2024 endedAccounts: net assets £119.5k, 1 employee
  4. Grahaem BROWN resignedDirector
  5. Dr. Grahaem Brown ceased to be a person with significant control
  6. Financial year 2023 endedAccounts: net assets £149.1k, 2 employees
  7. Financial year 2022 endedAccounts: net assets £250.1k, 2 employees
  8. Financial year 2021 endedAccounts: net assets £171.7k, 1 employee
Earlier events (15)
  1. Financial year 2020 endedAccounts: net assets £204.9k, 1 employee
  2. Ms Eva Hurst registered as a person with significant control
  3. Eva HURST appointedDirector
  4. Dr. Grahaem Brown registered as a person with significant control
  5. Bernard CHAN resignedDirector
  6. Michael James Byron TANSEY resignedDirector
  7. Bernard CHAN appointedDirector
  8. Name changed to COMPETITIVE DRUG DEVELOPMENT INTERNATIONAL LIMITEDPreviously CDDI LIMITED
  9. Gyongyi SALLA resignedSecretary
  10. Elizabeth Charlotte ROMAN resignedDirector
  11. Elizabeth Charlotte ROMAN appointedDirector
  12. Gyongyi SALLA appointedSecretary
  13. Grahaem BROWN appointedDirector
  14. Michael James Byron TANSEY appointedDirector
  15. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.